[en] C-terminal fragments of the Alzheimer amyloid peptide (amino acids 29-40 and 29-42) have physico-chemical properties related to those of the fusion peptides of viral proteins and they are able to induce the fusion of liposomes in vitro. We proposed that these properties could mediate a direct interaction of the amyloid peptide with cell membranes and account for part of the cytotoxicity of the amyloid peptide. In view of the epidemiologic and biochemical linkages between the pathology of Alzheimer's disease and apolipoprotein E (apoE) polymorphism, we examined the potential interaction between the three common apoE isoforms and the C-terminal fragments of the amyloid peptide. We show that, at low concentration, only apoE2 and apoE3 are potent inhibitors of the amyloid peptide fusogenic and aggregational properties, whereas the apoE4 isoform has no effect. We further show that the protective effect of apoE is mediated by the formation of stable apoE/amyloid peptide complexes, as determined by tryptophan emission fluorescence measurements and by gel electrophoresis. The interaction specificity between apoE2 and apoE3 and the amyloid fragments is demonstrated here, since other apolipoproteins (e.g. apolipoprotein A-I and A-II), with similar amphipathic structures, do not interact with the amyloid C-terminal fragments. Finally, we show that, reciprocally, the amyloid peptide can interact directly with the apoE2 and apoE3 isoforms to decrease or perturb their normal association with lipids. These data suggest that the 29-40 and 29-42 domains of the amyloid peptide could be critical for the amyloid-apoE interaction, and that apoE2 and apoE3 isoforms, but not apoE4, could play a protective role against the formation of amyloid aggregates and/or against their interaction with cellular membranes.
Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C.‐S. C. & Lindgren, F. T. (1988) Human apolipoprotein E3 in aqueous solution. 11. Properties of the amino‐ and carboxyterminal domains, J. Biol. Chem. 263, 6249–6258.
Arispe, N., Pollarde, H. B. & Rojas, E. (1993a) Giant multilevel cation channels formed by Alzheimer disease amyloid β‐protein (AβP‐(1–40)) in bilayer membranes, Proc. Natl Acad. Sci. USA 90, 10573–10577.
Arispe, N., Pollarde, H. B. & Rojas, E. (1993b) Alzheimer disease amyloid β‐protein forms calcium channels in bilayer membranes: blockage by tromethanine and aluminium, Proc. Natl Acad. Sci. USA 90, 567–571.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C. & Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs, J. Biol. Chem. 267, 546–554.
Come, J. H., Fraser, P. E. & Lansbury, P. T. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding, Proc. Natl Acad. Sci. USA 90, 5959–5963.
De Pauw, M., Vanloo, B., Weisgraber, K. H. & Rosseneu, M. (1995) Comparison of lipid‐binding and lecithin: cholesterol acyltransferase activation of the amino‐ and carboxy‐terminal domains of human apolipoprotein E3, Biochemistry, 34, 10953–10960.
Dong, L. M., Parkin, S., Trakhanov, S. D., Rupp, B., Simmons, T., Arnold, K. S., Newhouse, Y. M., Innerarity, T. L. & Weisgraber, K. H. (1996) Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia, Nature Struct. Biol. 3, 718–722.
Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H. & Lansbury, P. T. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease, Proc. Natl Acad. Sci. USA 92, 763–767.
Halverson, K., Fraser, P. E., Kirschner, D. A. & Lansbury, P. T. (1990) Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic b‐protein fragments, Biochemistry 29, 2639–2644.
Hilbich, C., Kisters‐Woike, B., Reed, J., Masters, C. L. & Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease, J. Mol. Biol. 218, 149–163.
Horth, M., Lambrecht, B., Khim, M. C. L., Bex, F., Thiriard, C., Ruysschaert, J. M., Burny, A. & Brasseur, R. (1991) Theoretical and functional analysis of the SIV fusion peptide, EMBO J. 10, 2747–2755.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680–685.
Lansbury, P. T., Costa, P. R., Griffiths, J. M., Simon, E. J., Auger, M., Halverson, K. J., Kocisko, D. A., Hendsch, Z. S., Ashburn, T. T., Spencer, R. G. S., Tidor, B. & Griffin, R. G. (1995) Structural model for the β‐amyloid fibril based on interstrand aligment of an anti‐parallel‐sheet comprising a C‐terminal peptide, Nat. Struct. Biol. 2, 990–998.
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265–275.
Martin, I., Dubois, M. C., Saerkman, T. & Ruysschaert, J. M. (1992) Apolipoprotein A‐I interacts with the N‐terminal fusogenic domains of SIV (Simian Immunodeficiency Virus) GP32 and HIV (Human Immunodeficiency Virus) GP41: implications in viral entry, Biochem. Biophys. Res. Commun. 186, 95–101.
Mattson, M. P. (1995) Untangling the pathophysiochemistry of β‐amyloid, Nat. Struct. Biol. 2, 926–928.
Morris, S. J., Bradley, D., Gibson, C. C., Smith, P. D. & Blumenthal, R. (1988) Use of membrane‐associated fluorescence probes to monitor fusion of bilayer vesicles: application to rapid kinetics using pyrene excimer/monomer fluorescence, in Spectroscopic membrane probes ( Loem, L. M., ed.) pp. 161–191, CRC Press, Boca Raton FL.
Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1993) Neurodegeneration induced by beta‐amyloid peptides in vifro: the role of peptide assembly state, J. Neurosci. 13, 1676–1687.
Pillot, T., Goethals, M., Vanloo, B., Talussot, C., Brasseur, R., Rosseneu, M., Vandekerckhove, J. & Lins, L. (1996a) Fusogenic properties of C‐terminal domains of the Alzheimer β‐amyloid peptide, J. Biol. Chem. 271, 28757–28765.
Pillot, T., Barbier, A., Visvikis, A., Lozac'h, K., Rosseneu, M., Vandekerckhove, J. & Siest, G. (1996b) Single step purification of two functional apolipoprotein E variants hyperexpressed in E. coli, Protein Express. Purif 7, 407–414.
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D. & Weisgraber, K. H. (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain, J. Biol. Chem. 262, 14352–14360.
Rapaport, D. & Shai, Y. (1994) Interaction of fluorescently labeled analogues of the amino‐terminal fusion peptide of Sebdai Virus with phospholipid membranes, J. Biol. Chem. 269, 15124–15131.
Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y. & Kimura, H. (1995) Amyloid peptides are toxic via a common oxidative mechanism, Proc. Natl Acad. Sci. USA 92, 1989–1993.
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Too, S. H., Pericak‐Vance, M.‐A., Goldgaber, D. & Roses, A. D. (1993) Increase amyloid p‐peptide deposition in cerebral cortex as a consequence of apoliprotein E genotype in late‐onset Alzheimer disease, Proc. Natl Acad. Sci. USA 90, 9649–9653.
Selkoe, D. J. (1994) Amyloid β‐protein precursor: new clues to the genesis of Alzheimer's disease, Cum Opin. Neurobiol. 4, 708–716.
Srinivas, R. V., Birkedal, B., Owens, R. J., Anantharamaiah, G. M., Segrest, J. P. & Compans, R. W. (1990) Antiviral effects of apolipoprotein A‐1 and its synthetic amphipathic peptide analogs, Virology 176, 48–57.
Strittmatter, W. J., Saunders, A., Schmechel, D., Pericak‐Vance, M., Englhild, J., Salvesen, O. S. & Roses, A. D. (1993a) Apolipoprotein E: high‐avidity binding to [hmyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease, Proc. Natl Acad. Sci. USA 90, 1977–1981.
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak‐Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. & Roses, A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid beta‐peptide: isoform‐specific effects and implications for late‐onset Alzheimer disease, Proc. Natl Acad. Sci. USA 90, 8098–8102.
Vanloo, B., Morrison, J., Fidge, N., Lorent, G., Lins, L., Brasseur, R., Ruysschaert, J. M., Baert, J. & Rosseneu, M. (1991) Characterization of discoidal complexes formed between apoA‐I‐CNBr fragments and phosphatidylcholine, J. Lipid Res. 32, 1253–1264.
Vanloo, B., Taveirne, J., Baert, G., Lorent, G., Vercaemst, R., Lins, L., Ruysschaert, J. M. & Rosseneu, M. (1992) Activation of lecithin cholesterol acyl transferase (LCAT) by the CNBr fragments of human apo AI and conversion of the discoidal complexes into spherical particles, Biochim. Biophys. Acta 1128, 258–266.
Vonèche, V., Portetelle, D., Kettman, R., Willemms, L., Limbach, K., Paoletti, E., Ruysschaert, J. M., Burny, A. & Brasseur, R. (1992) Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells, Proc. Natl Acad. Sci. USA 89, 3810–3814.
Weisgraber, K. H. (1994) Apolipoprotein E: Structure‐function relationship, Adv. Protein Chem. 45, 249–295.
Weisgraber, K. H., Roses, A. D. & Strittmatter, W. J. (1994) The role of apolipoprotein E in the nervous system, Curr: Opin. Lipidol. 5, 110–116.
Weiss, J. H., Pike, C. J. & Cotman, C. W. (1994) Ca 2+ channel blockers attenuate β‐amyloid peptide toxicity to cortical neurons in culture, J. Neurochem. 62, 372–375.
Westerlund, J. A. & Weisgraber, K. H. (1993) Discrete carboxyl‐terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization, J. Biol. Chem. 268, 15745–15750.
Whitson, J. S., Mims, M. P., Strittmatter, W. J., Yamaki, T., Morrisset, J. D. & Appel, S. H. (1994) Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E, Biochem. Biophys. Res. Commun. 199, 163–170.
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, K. W. & Agard, D. A. (1991) Three‐dimensional structure of the LDL receptor‐binding domain of human apolipoprotein E, Science 252, 1817–1822.
Wisniewski, T. & Frangione, B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett. 135, 235–238.
Wisniewski, T., Golabek, A. A., Kida, E., Wisniewski, K. E. & Frangione, B. (1995) Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis, Am. J. Pathol. 147, 238–244.
Zimmerberg, J., Vogel, S. S. & Chernomordik, L. V. (1993) Mechanism of membrane fusion, Annu. Rev. Biophys. Biomol. Struct. 22, 433–466.